Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired 110.8583 deferred stock units, increasing his beneficial ownership.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 110.8583 Deferred Stock Units (DSUs).
• The transaction date for the acquisition of these DSUs was February 20, 2026.
• Each DSU represents the right to receive one share of Company common stock or its cash equivalent.
• The DSUs were acquired at a price of $24.98 per unit.
• Following this transaction, Mr. Simmons beneficially owns a total of 19,179.7639 derivative securities.
• These DSUs will settle in cash or shares of Company common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine disclosure. The acquisition of deferred stock units by the CEO indicates continued alignment of management's interests with shareholder value, though it's a standard compensation event rather than a new strategic development.

Positives

• The acquisition of deferred stock units by the CEO aligns management's interests with those of shareholders, as the value of these units is tied to the company's stock performance.
• The transaction is part of a routine executive compensation plan, indicating ongoing commitment and incentivization for leadership.

Future Outlook

The deferred stock units are designed to settle in cash or shares of Company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan, indicating a long-term incentive structure.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of equity-linked compensation like deferred stock units by top executives, are common practices in the animal health industry and broader corporate landscape. These actions are typically part of executive compensation packages designed to align management incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of deferred stock units by the CEO can be seen as a positive signal, as it further aligns management's financial interests with the long-term performance of the company's stock, potentially encouraging decisions that enhance shareholder value.
• Employees: The executive compensation structure, including deferred stock units, may influence overall compensation philosophy and morale within the company, particularly among other executives.

Next Steps

• The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to executive compensation. While the acquisition of deferred stock units by the CEO is a positive for management alignment, it does not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. It is a standard disclosure that typically has minimal impact on short-term stock price movements.

Keywords

Elanco, ELAN, Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, CEO, Director, Stock Ownership